There are now two shots authorized for use against the mosquito-borne scourge, though companies like BioNTech and Moderna are hoping to compete using the same mRNA technology behind their successful Covid vaccines.
There are now two shots authorized for use against the mosquito-borne scourge, though companies like BioNTech and Moderna are hoping to compete using the same mRNA technology behind their successful Covid vaccines.